SERSTECH AB: Notice of Annual General Meeting in Serstech AB (publ.)
March 29, 2021 12:16 ET
|
Serstech
This notice is published in both the Swedish and the English language. In the event of inconsistency or discrepancy between the English version and the Swedish version of this publication, the Swedish...
SERSTECH AB: Serstech genomför en företrädesemission om 25MSEK
March 29, 2021 12:15 ET
|
SERSTECH AB
Serstech har under de tre senaste åren byggt upp och förfinat en välfungerande intern organisation och ett globalt distributionsnätverk, som idag består av 90 partners. Den kommersiella grunden lades...
SERSTECH AB: Serstech announces a rights issue of 25MSEK
March 29, 2021 12:15 ET
|
Serstech
This announcement is published in both the Swedish and the English language. In the event of inconsistency or discrepancy between the English version and the Swedish version of this...
Allarity Therapeutics plans fully guaranteed rights issue of approximately SEK 100 million
March 23, 2021 03:30 ET
|
Allarity Therapeutics A/S
- Proceeds will finance further development of three high-priority programs- Rights Issue is fully covered by subscription undertakings and guarantee commitments - The Company will discontinue the use...
Aedifica NV/SA: Admission to trading of new shares on the regulated market of Euronext Brussels and Euronext Amsterdam
October 27, 2020 03:08 ET
|
Aedifica
Please find below a press release issued by Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the admission to trading...
Aedifica NV/SA: Capital increase – final results
October 23, 2020 09:30 ET
|
Aedifica
Please find below a press release issued by Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the final results of the...
Aedifica NV/SA: Capital increase – preliminary results
October 23, 2020 04:16 ET
|
Aedifica
Please find below a press release issued by Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the preliminary results...
Rights issue oversubscribed
December 18, 2019 02:45 ET
|
SERSTECH AB
On December 12, 2019, the subscription period ended in Serstech AB´s (“Serstech”) rights issue. The rights issue was subscribed for a total of approx. SEK 32.9 million (excl. guarantee commitments),...
Nexstim Oyj: Warrant-ehtojen muuttaminen
May 23, 2019 11:30 ET
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 23.5.2019 klo 18.30 Nexstim Oyj: Warrant-ehtojen muuttaminen Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”), neuromodulaatioyritys, joka on kehittänyt...
Nexstim Plc: Amendment of terms of warrants
May 23, 2019 11:30 ET
|
Nexstim Oyj
Company announcement, Helsinki, 23 May 2019 at 6.30 PM Nexstim Plc: Amendment of terms of warrants Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation...